Bluezone Capital™ is an early-stage life sciences fund. By investing in AI-powered, scalable platforms and breakthrough technologies, we are accelerating the shift from treatment to cures, extending human health span like never before. 

Our mission? To break down cost and complexity barriers, turning regenerative medicine’s vast potential into reality while driving outsized returns.

Bluezone Capital™ is more than just capital. We are operators, scientists, and engineers with the deep expertise to identify and propel the next wave of game-changing companies.